Globus Medical (GMED) Tops Q1 EPS by 5c; Raises Outlook

Globus Medical (NYSE: GMED) reported Q1 EPS of $0.41, $0.05 better than the analyst estimate of $0.36. Revenue for the quarter came in at $174.4 million versus the consensus estimate of $167.89 million.

GUIDANCE:

Globus Medical sees FY2018 EPS of $1.52, versus prior of $1.50 and the consensus of $1.50. Globus Medical sees FY2018 revenue of $695 million, versus prior of $690 million and the consensus of $690.84 million.

For earnings history and earnings-related data on Globus Medical (GMED) click here.

You May Also Be Interested In

• FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
• Nike names former Pfizer CFO David Denton as new finance chief
• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance